LSTA
Lisata Therapeutics, Inc.
Price Chart
No historical data available
Latest Quote
$1.49
-0.20 (-11.83%)
Current Price
| Previous Close | $1.69 |
| Open | $1.66 |
| Day High | $1.66 |
| Day Low | $1.44 |
| Volume | 242,222 |
Stock Information
| Shares Outstanding | 9.01M |
| Cash Equivalents | $10.44M |
| Revenue | $100K |
| Net Income | $-14.62M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $13.43M |
| EPS (TTM) | $-1.64 |
| Exchange | NCM |
Recent Price History
No history data available. Data will be fetched automatically.
About Lisata Therapeutics, Inc.
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with range of anti-cancer regimens. Lisata Therapeutics, Inc. was formerly known as Caladrius Biosciences, Inc. and changed its name to Lisata Therapeutics, Inc. in September 2022. The company was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey. As of July 21, 2026, Lisata Therapeutics, Inc. operates as a subsidiary of Kuva Labs, Inc.
đ° Latest News
No news articles available at the moment. Check back later for updates on LSTA.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $170,000 | $1,000,000 | $0 | $0 |
| Operating Revenue | $170,000 | $1,000,000 | $0 | $0 |
| Expenses | ||||
| Total Expenses | $18,379,000 | $23,409,000 | $25,708,000 | $57,601,000 |
| Other Income Expense | $661,000 | $1,626,000 | $2,538,000 | $897,000 |
| Other Non Operating Income Expenses | $-145,000 | $-257,000 | $-186,000 | $-155,000 |
| Operating Expense | $18,379,000 | $23,409,000 | $25,708,000 | $57,601,000 |
| General And Administrative Expense | $10,430,000 | $12,075,000 | $12,974,000 | $14,141,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-16,586,000 | $-19,985,000 | $-20,840,000 | $-54,225,000 |
| Normalized Income | $-17,347,814 | $-21,795,699 | $-23,290,072 | $-55,231,008 |
| Net Income From Continuing And Discontinued Operation | $-16,586,000 | $-19,985,000 | $-20,840,000 | $-54,225,000 |
| Total Operating Income As Reported | $-18,209,000 | $-22,409,000 | $-25,708,000 | $-57,601,000 |
| Net Income Common Stockholders | $-16,586,000 | $-19,985,000 | $-20,840,000 | $-54,225,000 |
| Net Income | $-16,586,000 | $-19,985,000 | $-20,840,000 | $-54,225,000 |
| Net Income Including Noncontrolling Interests | $-16,586,000 | $-19,985,000 | $-20,840,000 | $-54,225,000 |
| Net Income Continuous Operations | $-16,586,000 | $-19,985,000 | $-20,840,000 | $-54,225,000 |
| Pretax Income | $-17,548,000 | $-20,783,000 | $-23,170,000 | $-56,704,000 |
| Operating Income | $-18,209,000 | $-22,409,000 | $-25,708,000 | $-57,601,000 |
| Per Share | ||||
| Diluted EPS | $-1.91 | $-2.40 | $-2.58 | $-10.47 |
| Basic EPS | $-1.91 | $-2.40 | $-2.58 | $-10.47 |
| Other | ||||
| Tax Effect Of Unusual Items | $44,186 | $72,301 | $273,928 | $45,992 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-18,869,000 | $-24,118,000 | $-28,243,000 | $-58,584,000 |
| Total Unusual Items | $806,000 | $1,883,000 | $2,724,000 | $1,052,000 |
| Total Unusual Items Excluding Goodwill | $806,000 | $1,883,000 | $2,724,000 | $1,052,000 |
| Reconciled Depreciation | $146,000 | $174,000 | $189,000 | $69,000 |
| EBITDA (Bullshit earnings) | $-18,063,000 | $-22,235,000 | $-25,519,000 | $-57,532,000 |
| EBIT | $-18,209,000 | $-22,409,000 | $-25,708,000 | $-57,601,000 |
| Diluted Average Shares | $8,687,000 | $8,329,000 | $8,073,000 | $5,180,000 |
| Basic Average Shares | $8,687,000 | $8,329,000 | $8,073,000 | $5,180,000 |
| Diluted NI Availto Com Stockholders | $-16,586,000 | $-19,985,000 | $-20,840,000 | $-54,225,000 |
| Minority Interests | $0 | $0 | $0 | $0 |
| Tax Provision | $-962,000 | $-798,000 | $-2,330,000 | $-2,479,000 |
| Gain On Sale Of Security | $806,000 | $1,883,000 | $2,724,000 | $1,052,000 |
| Research And Development | $7,949,000 | $11,334,000 | $12,734,000 | $43,460,000 |
| Selling General And Administration | $10,430,000 | $12,075,000 | $12,974,000 | $14,141,000 |
| Other Gand A | $10,430,000 | $12,075,000 | $12,974,000 | $14,141,000 |
Fetched: 2026-08-31
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $14,855,000 | $29,379,000 | $47,885,000 | $66,244,000 |
| Total Assets | $17,744,000 | $35,002,000 | $54,694,000 | $73,034,000 |
| Total Non Current Assets | $41,000 | $424,000 | $770,000 | $1,158,000 |
| Other Non Current Assets | $23,000 | $160,000 | $332,000 | $528,000 |
| Goodwill And Other Intangible Assets | $0 | $192,000 | $263,000 | $334,000 |
| Current Assets | $17,703,000 | $34,578,000 | $53,924,000 | $71,876,000 |
| Other Current Assets | $1,747,000 | $2,433,000 | $3,389,000 | $2,650,000 |
| Receivables | $0 | $900,000 | $0 | - |
| Accounts Receivable | $0 | $900,000 | $0 | - |
| Cash Cash Equivalents And Short Term Investments | $15,956,000 | $31,245,000 | $50,535,000 | $69,226,000 |
| Cash And Cash Equivalents | $15,956,000 | $16,209,000 | $22,593,000 | $32,154,000 |
| Other Intangible Assets | - | $192,000 | $263,000 | $334,000 |
| Cash Equivalents | - | - | $16,715,000 | $27,668,000 |
| Cash Financial | - | - | $5,878,000 | $4,486,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $0 | $137,000 | $168,000 | $180,000 |
| Current Debt And Capital Lease Obligation | - | $137,000 | $168,000 | $180,000 |
| Long Term Debt And Capital Lease Obligation | - | - | - | $305,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $3,143,000 | $5,685,000 | $6,800,000 | $6,710,000 |
| Total Non Current Liabilities Net Minority Interest | $72,000 | $72,000 | $210,000 | $327,000 |
| Other Non Current Liabilities | $72,000 | $72,000 | $210,000 | $327,000 |
| Current Liabilities | $3,071,000 | $5,613,000 | $6,590,000 | $6,383,000 |
| Payables And Accrued Expenses | $3,071,000 | $5,476,000 | $6,422,000 | $6,203,000 |
| Payables | $1,019,000 | $1,284,000 | $2,421,000 | $2,655,000 |
| Accounts Payable | $1,019,000 | $1,284,000 | $2,421,000 | $2,655,000 |
| Equity | ||||
| Common Stock Equity | $14,855,000 | $29,571,000 | $48,148,000 | $66,578,000 |
| Total Equity Gross Minority Interest | $14,601,000 | $29,317,000 | $47,894,000 | $66,324,000 |
| Stockholders Equity | $14,855,000 | $29,571,000 | $48,148,000 | $66,578,000 |
| Gains Losses Not Affecting Retained Earnings | $-37,000 | $-81,000 | $-42,000 | $-29,000 |
| Other Equity Adjustments | $-37,000 | $-81,000 | $-42,000 | $-29,000 |
| Retained Earnings | $-564,652,000 | $-548,066,000 | $-528,081,000 | $-507,241,000 |
| Other | ||||
| Treasury Shares Number | $738 | $738 | $738 | $738 |
| Ordinary Shares Number | $8,833,875 | $8,408,844 | $8,149,897 | $7,900,000 |
| Share Issued | $8,834,613 | $8,409,582 | $8,150,635 | $7,900,738 |
| Tangible Book Value | $14,855,000 | $29,379,000 | $47,885,000 | $66,244,000 |
| Invested Capital | $14,855,000 | $29,571,000 | $48,148,000 | $66,578,000 |
| Working Capital | $14,632,000 | $28,965,000 | $47,334,000 | $65,493,000 |
| Capital Lease Obligations | $0 | $137,000 | $168,000 | $180,000 |
| Total Capitalization | $14,855,000 | $29,571,000 | $48,148,000 | $66,578,000 |
| Minority Interest | $-254,000 | $-254,000 | $-254,000 | $-254,000 |
| Treasury Stock | $708,000 | $708,000 | $708,000 | $708,000 |
| Additional Paid In Capital | $580,243,000 | $578,418,000 | $576,971,000 | $574,548,000 |
| Capital Stock | $9,000 | $8,000 | $8,000 | $8,000 |
| Common Stock | $9,000 | $8,000 | $8,000 | $8,000 |
| Current Capital Lease Obligation | $0 | $137,000 | $168,000 | $180,000 |
| Current Accrued Expenses | $2,052,000 | $4,192,000 | $4,001,000 | $3,548,000 |
| Net PPE | $18,000 | $72,000 | $175,000 | $296,000 |
| Accumulated Depreciation | $-476,000 | $-589,000 | $-486,000 | $-417,000 |
| Gross PPE | $494,000 | $661,000 | $661,000 | $713,000 |
| Leases | $0 | $72,000 | $72,000 | $99,000 |
| Machinery Furniture Equipment | $494,000 | $589,000 | $589,000 | $614,000 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $0 | $15,036,000 | $27,942,000 | $37,072,000 |
| Preferred Stock | - | - | - | $0 |
| Long Term Capital Lease Obligation | - | - | - | $305,000 |
Fetched: 2026-08-31
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-15,977,000 | $-19,356,000 | $-20,032,000 | $-21,455,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-15,949,000 | $-19,356,000 | $-20,032,000 | $-21,170,000 |
| Cash Flow From Continuing Operating Activities | $-15,949,000 | $-19,356,000 | $-20,032,000 | $-21,170,000 |
| Operating Gains Losses | - | $130,000 | $3,000 | - |
| Investing Activities | ||||
| Capital Expenditure | $-28,000 | - | - | $-285,000 |
| Investing Cash Flow | $15,086,000 | $13,233,000 | $10,102,000 | $28,911,000 |
| Cash Flow From Continuing Investing Activities | $15,086,000 | $13,233,000 | $10,102,000 | $28,911,000 |
| Net Other Investing Changes | - | - | - | $-3,320,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $844,000 | $68,000 | $321,000 | $43,000 |
| Financing Cash Flow | $599,000 | $-206,000 | $385,000 | $-224,000 |
| Cash Flow From Continuing Financing Activities | $599,000 | $-206,000 | $385,000 | $-224,000 |
| Net Other Financing Charges | $-253,000 | $-274,000 | $-91,000 | $-267,000 |
| Net Common Stock Issuance | $844,000 | $68,000 | $321,000 | $43,000 |
| Common Stock Issuance | $844,000 | $68,000 | $321,000 | $43,000 |
| Other | ||||
| End Cash Position | $15,956,000 | $16,209,000 | $22,593,000 | $32,154,000 |
| Beginning Cash Position | $16,209,000 | $22,593,000 | $32,154,000 | $24,647,000 |
| Effect Of Exchange Rate Changes | $11,000 | $-55,000 | $-16,000 | $-10,000 |
| Changes In Cash | $-264,000 | $-6,329,000 | $-9,545,000 | $7,517,000 |
| Proceeds From Stock Option Exercised | $8,000 | $0 | $155,000 | $0 |
| Net Investment Purchase And Sale | $15,114,000 | $13,363,000 | $10,102,000 | $32,516,000 |
| Sale Of Investment | $24,294,000 | $69,051,000 | $108,581,000 | $122,203,000 |
| Purchase Of Investment | $-9,180,000 | $-55,688,000 | $-98,479,000 | $-89,687,000 |
| Net Business Purchase And Sale | $0 | $-130,000 | $0 | - |
| Purchase Of Business | $0 | $-130,000 | $0 | - |
| Net PPE Purchase And Sale | $-28,000 | $0 | $0 | $-285,000 |
| Purchase Of PPE | $-28,000 | $0 | $0 | $-285,000 |
| Change In Working Capital | $-1,287,000 | $-873,000 | $-462,000 | $-831,000 |
| Change In Other Current Assets | $140,000 | $170,000 | $274,000 | $237,000 |
| Change In Payables And Accrued Expense | $-2,570,000 | $-995,000 | $88,000 | $-223,000 |
| Change In Payable | $-2,570,000 | $-995,000 | $88,000 | - |
| Change In Account Payable | $-2,570,000 | $-995,000 | $88,000 | - |
| Change In Prepaid Assets | $742,000 | $852,000 | $-824,000 | $-845,000 |
| Change In Receivables | $401,000 | $-900,000 | $0 | - |
| Changes In Account Receivables | $401,000 | $-900,000 | $0 | - |
| Stock Based Compensation | $1,226,000 | $1,653,000 | $2,038,000 | $2,636,000 |
| Provisionand Write Offof Assets | $500,000 | $0 | - | - |
| Asset Impairment Charge | $127,000 | $0 | - | - |
| Amortization Of Securities | $-75,000 | $-455,000 | $-960,000 | $788,000 |
| Depreciation Amortization Depletion | $146,000 | $174,000 | $189,000 | $69,000 |
| Depreciation And Amortization | $146,000 | $174,000 | $189,000 | $69,000 |
| Earnings Losses From Equity Investments | $0 | $130,000 | $0 | - |
| Net Income From Continuing Operations | $-16,586,000 | $-19,985,000 | $-20,840,000 | $-54,225,000 |
| Gain Loss On Sale Of PPE | - | $0 | $3,000 | $0 |
| Other Non Cash Items | - | - | - | $30,393,000 |
| Interest Paid Supplemental Data | - | - | - | - |
| Income Tax Paid Supplemental Data | - | - | - | - |
Fetched: 2026-08-31